跳至主要内容
临床试验/NCT04542031
NCT04542031已完成不适用

COVID-19 Prevalence in a Single Large UK Rheumatology Centre and the Impact on Quality of Life From Stringent Social Distancing

The Royal Wolverhampton Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 1,010 人开始时间: 2020年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,010
试验地点
2
主要终点
Prevalence of COVID 19

研究概览

简要总结

The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology of COVID-19 in the rheumatological population is largely unknown large case registries are beginning to show potential drug treatment interactions. Strict self-isolation (shielding) has been recommended for those deemed 'high risk' although its impact on the likelihood of COVID-19 infection and health related quality of life (HRQoL) is unclear.

The study aims to explore how this unprecedented situation has impacted the Trust patients primarily evaluating prevalence of the infection, effect of stringent social distancing (shielding) and Quality of Life (QOL). This will be done via a voluntary questionnaire, sent via text messaging at 6 and 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All rheumatology patients under active follow up at the Royal Wolverhampton Trust with a validated mobile telephone number

排除标准

  • Patients without a validated mobile phone number linked to their hospital record

结局指标

主要结局

Prevalence of COVID 19

时间窗: 1 year

percentage of cases

Mortality rates from COVID 19

时间窗: 1 year

number of deaths per 1000 individuals

Health related quality of life - Short Form 12

时间窗: 1 year

mental and physical component scores through patient reported outcomes. Normative score set at 50 with minimum score being 0 and maximum score being 100. Scores \>50 indicate better mental or physical health than the mean. Scores \<50 indicate worse mental or physical health than the mean

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验